» Articles » PMID: 35610230

Phenomenology and Content of the Inhaled N, N-dimethyltryptamine (N, N-DMT) Experience

Overview
Journal Sci Rep
Specialty Science
Date 2022 May 24
PMID 35610230
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the phenomenology and content of the inhaled N, N, dimethyltryptamine (N, N-DMT) experience is critical to facilitate and support ongoing research and therapeutic models targeting mental health conditions and central nervous system pathology. A qualitative analysis was conducted of all N, N-DMT experiences posted to the r/DMT Reddit community over a 10-year period from 2009 to 2018. A total of 3778 experiences from 3305 posts were included in this study. A median dose of N, N-DMT of 40.0 mg [interquartile range (IQR), 27.5 to 50.0] and a median experience duration of 10 min (IQR, 5.0 to 15.0) were identified. The most common somatic effects were somaesthesias (n = 1415, 37.5%) and an auditory ringing (n = 583, 15.4%). Visualizations predominantly consisted of fractals, shapes, patterns (n = 1231, 32.6%) and vivid colours (n = 953, 25.2%). Entity encounters were reported in 45.5% (n = 1719) of the experiences and involved predominantly a feminine phenotype (n = 416, 24.2%); deities (n = 293, 17.0%); aliens (n = 281, 16.3%); creature-based entities (n = 158, 9.2%, including reptilian and insectoid beings); mythological beings (n = 144, 8.4%, including machine elves); and jesters (n = 112, 6.5%). Entity interactions were predominantly positive (n = 600, 34.9% of encounters) involving benevolent, comforting, protecting, or outwardly caring interactions. A companion-type, pedagogical, or guide-type interaction was identified 32.4% of encounters (n = 557). Common typology, architecture, and structural features of the "DMT world" included descriptions of alternate or higher dimensions (n = 952, 25.2%); rooms [n = 582, 15.4%, including the "waiting room" (n = 105, 2.8%)], and a tunnel (n = 390, 10.3%). Features of mystical and ego-dissolution experiences were common. Additional rewarding aspects were identified, including a sense of familiarity and the acceptance/removal of the fear of death. Challenging and difficult responses were less frequent but also documented. Statements of profundity were identified in 232 experiences (6.1%), including pronouncing the experience or an aspect of the experience as the most "beautiful" or feeling the most "beautiful" of their life (n = 47, 1.2%). This study identified common phenomenological themes and content of naturalistic inhaled N, N-DMT experiences. Major thematic domains included (1) physical and somatic experiences; (2) visualizations and imagery; (3) entity encounters including entity phenotype, descriptors, attributes, disposition, and characteristics of the interaction; (4) typology, architectural features, structural characteristics, and scenery of the "DMT world"; (5) alerations in consciousness (including mystical experiences, out-of-body experiences, and ego-dissolution); (6) emotional responses (including positive, rewarding, difficult, and challenging); and (7) statements of profundity.

Citing Articles

Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors.

Jiwani Z, Goldberg S, Stroud J, Young J, Curtin J, Dunne J PLoS One. 2025; 20(2):e0310160.

PMID: 39937729 PMC: 11819602. DOI: 10.1371/journal.pone.0310160.


The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample.

Calder A, Qualls C, Hasler G, Elmiger D, Strassman R Biol Psychiatry Glob Open Sci. 2025; 5(2):100436.

PMID: 39926700 PMC: 11804565. DOI: 10.1016/j.bpsgos.2024.100436.


The Psychedelic Renaissance: A Catholic Perspective.

Carroll T Linacre Q. 2024; :00243639241274818.

PMID: 39544399 PMC: 11559537. DOI: 10.1177/00243639241274818.


Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors.

Jiwani Z, Goldberg S, Stroud J, Young J, Curtin J, Dunne J medRxiv. 2024; .

PMID: 39252913 PMC: 11383514. DOI: 10.1101/2024.08.27.24312677.


Documenting and defining emergent phenomenology: theoretical foundations for an extensive research strategy.

Sandilands O, Ingram D Front Psychol. 2024; 15:1340335.

PMID: 39114586 PMC: 11304085. DOI: 10.3389/fpsyg.2024.1340335.


References
1.
Glennon R, Titeler M, McKenney J . Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984; 35(25):2505-11. DOI: 10.1016/0024-3205(84)90436-3. View

2.
Alonso J, Romero S, Angel Mananas M, Riba J . Serotonergic psychedelics temporarily modify information transfer in humans. Int J Neuropsychopharmacol. 2015; 18(8). PMC: 4571623. DOI: 10.1093/ijnp/pyv039. View

3.
Hase A, Erdmann M, Limbach V, Hasler G . Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology (Berl). 2022; 239(2):643-659. PMC: 8799548. DOI: 10.1007/s00213-022-06062-3. View

4.
Alamia A, Timmermann C, Nutt D, VanRullen R, Carhart-Harris R . DMT alters cortical travelling waves. Elife. 2020; 9. PMC: 7577737. DOI: 10.7554/eLife.59784. View

5.
Lea T, Amada N, Jungaberle H . Psychedelic Microdosing: A Subreddit Analysis. J Psychoactive Drugs. 2019; 52(2):101-112. DOI: 10.1080/02791072.2019.1683260. View